[1] EL-RASHIDY AA, ROETHER JA, HARHAUS L, et al. Regenerating bone with bioactive glass scaffolds: A review of in vivo studies in bone defect models. Acta Biomater. 2017;62:1-28.
[2] 李祖浩,王辰宇,王中汉.骨质疏松性骨缺损的治疗进展:支架植入与局部药物递送[J].中国组织工程研究,2018,22(18):2939-2945.
[3] BUHRMANN C, HONARVAR A, SETAYESHMEHR M, et al. Herbal Remedies as Potential in Cartilage Tissue Engineering: An Overview of New Therapeutic Approaches and Strategies. Molecules. 2020;25(13): 3075.
[4] AWALE G, WONG E, RAJPURA K, et al. Engineered Bone Tissue with Naturally-Derived Small Molecules. Curr Pharm Des. 2017;23(24): 3585-3594.
[5] WU Y, XIA L, ZHOU Y, et al. Evaluation of osteogenesis and angiogenesis of icariin loaded on micro/nano hybrid structured hydroxyapatite granules as a local drug delivery system for femoral defect repair. J Mater Chem B. 2015;3(24):4871-4883.
[6] 刘永庆,李琪佳,甘洪全,等.葛根素联合国产多孔钽对人成骨细胞COL-I、OC、OPN表达和细胞增殖的影响[J].中国骨质疏松杂志, 2017,23(2):236-243.
[7] AN J, YANG H, ZHANG Q, et al. Natural products for treatment of osteoporosis: The effects and mechanisms on promoting osteoblast-mediated bone formation. Life Sci. 2016;147:46-58.
[8] XU Y, LI L, TANG Y, et al. Icariin promotes osteogenic differentiation by suppressing Notch signaling. Eur J Pharmacol. 2019;865:172794.
[9] SUZUKI H, TATEI K, OHSHIMA N, et al. Regulation of MC3T3-E1 differentiation by actin cytoskeleton through lipid mediators reflecting the cell differentiation stage. Biochem Biophys Res Commun. 2019; 514(2):393-400.
[10] ZENG X, FENG Q, ZHAO F, et al. Puerarin inhibits TRPM3/miR-204 to promote MC3T3-E1 cells proliferation, differentiation and mineralization. Phytother Res. 2018;32(6):996-1003.
[11] WANG Z, WANG D, YANG D, et al. The effect of icariin on bone metabolism and its potential clinical application. Osteoporos Int. 2018; 29(3):535-544.
[12] 何罕亮.雌激素对成骨细胞MC3T3-E1的影响及其相关机制研究[D].苏州:苏州大学,2018.
[13] CLEMENTINI M, MORLUPI A, AGRESTINI C, et al. Immediate versus delayed positioning of dental implants in guided bone regeneration or onlay graft regenerated areas: a systematic review. Int J Oral Maxillofac Surg. 2013;42(5):643-650.
[14] LU J, HAO Y, ZHAO W, et al. Molecular, Cellular and Pharmaceutical Aspects of Autologous Grafts for Peri-implant Hard and Soft Tissue Defects. Curr Pharm Biotechnol. 2017;18(1):85-94.
[15] YAMADA Y, HARA K, NAKAMURA S, et al. Minimally invasive approach with tissue engineering for severe alveolar bone atrophy case. Int J Oral Maxillofac Surg. 2013;42(2):260-263.
[16] KŘÍŽOVÁ L, DADÁKOVÁ K, KAŠPAROVSKÁ J, et al. Isoflavones. Molecules. 2019;24(6):1076.
[17] SIROTKIN AV, HARRATH AH. Phytoestrogens and their effects. Eur J Pharmacol. 2014;741:230-236.
[18] WANG Y, WANG WL, XIE WL, et al. Puerarin stimulates proliferation and differentiation and protects against cell death in human osteoblastic MG-63 cells via ER-dependent MEK/ERK and PI3K/Akt activation. Phytomedicine. 2013;20(10):787-796.
[19] YANG X, ZHENG H, LIU Y, et al. Puerarin for OVX-Induced Postmenopausal Osteoporosis in Murine Model: Systematic Review and Meta-Analysis. Curr Stem Cell Res Ther. 2020;15(1):37-42.
[20] XIE L, LIU N, XIAO Y, et al. In Vitro and In Vivo Osteogenesis Induced by Icariin and Bone Morphogenetic Protein-2: A Dynamic Observation. Front Pharmacol. 2020;11:1058.
[21] HO MX, POON CC, WONG KC, et al. Icariin, but Not Genistein, Exerts Osteogenic and Anti-apoptotic Effects in Osteoblastic Cells by Selective Activation of Non-genomic ERα Signaling. Front Pharmacol. 2018;9:474.
[22] URASOPON N, HAMADA Y, CHERDSHEWASART W, et al. Preventive effects of Pueraria mirifica on bone loss in ovariectomized rats. Maturitas. 2008;59(2):137-148.
[23] TIYASATKULKOVIT W, MALAIVIJITNOND S, CHAROENPHANDHU N, et al. Pueraria mirifica extract and puerarin enhance proliferation and expression of alkaline phosphatase and type I collagen in primary baboon osteoblasts. Phytomedicine. 2014;21(12):1498-1503.
[24] HO-SHUI-LING A, BOLANDER J, RUSTOM LE, et al. Bone regeneration strategies: Engineered scaffolds, bioactive molecules and stem cells current stage and future perspectives. Biomaterials. 2018;180:143-162.
[25] FENG Q, CHENG SY, YANG R, et al. Puerarin promotes the viability and differentiation of MC3T3-E1 cells by enhancing LC3B-mediated autophagy through downregulation of miR-204. Exp Ther Med. 2020; 19(2):883-890.
[26] 吴曦,彭锐.不同浓度淫羊藿苷对人骨髓间充质干细胞成骨分化的影响[J].中国组织工程研究,2018,22(5):669-674.
[27] 张姝江,李颖,白波,等.中药骨康方对体外培养大鼠成骨细胞骨架保护作用的初步实验研究[J].世界中医药,2016,11(5):880-883.
[28] WEI Q, WANG B, HU H, et al. Icaritin promotes the osteogenesis of bone marrow mesenchymal stem cells via the regulation of sclerostin expression. Int J Mol Med. 2020;45(3):816-824.
[29] YANG A, YU C, LU Q, et al. Mechanism of Action of Icariin in Bone Marrow Mesenchymal Stem Cells. Stem Cells Int. 2019;2019:5747298.
[30] HONG D, CHEN HX, YU HQ, et al. Morphological and proteomic analysis of early stage of osteoblast differentiation in osteoblastic progenitor cells. Exp Cell Res. 2010;316(14):2291-2300.
[31] SHANBHAG S, PANDIS N, MUSTAFA K, et al. Bone tissue engineering in oral peri-implant defects in preclinical in vivo research: A systematic review and meta-analysis. J Tissue Eng Regen Med. 2018;12(1): e336-e349.
[32] RISTELI L, RISTELI J. Biochemical markers of bone metabolism. Ann Med. 1993;25(4):385-393.
[33] ZHAN XQ, ZENG XW, ZHANG YY, et al. Puerarin promotes the viability and differentiation of MC3T3‑E1 cells by miR‑204‑regulated Runx2 upregulation. Mol Med Rep. 2017;16(5):6262-6268.
[34] BOYLE WJ, SIMONET WS, LACEY DL. Osteoclast differentiation and activation. Nature. 2003;423(6937):337-342.
|